Literature DB >> 12237273

Cancer risks in BRCA1 carriers: time for the next generation of studies.

Stephen B Gruber, Gloria M Petersen.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12237273     DOI： 10.1093/jnci/94.18.1344

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan.

Authors:  Muhammad U Rashid; Sidra Gull; Saima Faisal; Saba Khaliq; Kashif Asghar; Neelam Siddiqui; Asim Amin; Ute Hamann
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

2.  BRCA1 mutations and colorectal cancer in Poland.

Authors:  Janina Suchy; Cezary Cybulski; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Tadeusz Dębniak; Jacek Gronwald; Anna Jakubowska; Dominika Wokołorczyk; Grzegorz Kurzawski; Józef Kładny; Arkadiusz Jawień; Zbigniew Banaszkiewicz; Rafał Wiśniowski; Piotr Wandzel; Jacek Starzewski; Zbigniew Lorenc; Elżbieta Korobowicz; Piotr Krokowicz; Karolina Horbacka; Jan Lubiński; Steven A Narod
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 3.  Skin cancer risk in BRCA1/2 mutation carriers.

Authors:  P V Gumaste; L A Penn; R M Cymerman; T Kirchhoff; D Polsky; B McLellan
Journal:  Br J Dermatol       Date:  2015-04-29       Impact factor: 9.302

4.  Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations.

Authors:  Luna Kadouri; Ayala Hubert; Yakir Rotenberg; Tamar Hamburger; Michal Sagi; Chovav Nechushtan; Dvorah Abeliovich; Tamar Peretz
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

5.  Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.

Authors:  Luna Kadouri; Mark Temper; Tal Grenader; Dvorah Abeliovich; Tamar Hamburger; Tamar Peretz; Michal Lotem
Journal:  Fam Cancer       Date:  2008-08-05       Impact factor: 2.375

6.  Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.

Authors:  Wigdan Al-Sukhni; Heidi Rothenmund; Ayelet Eppel Borgida; George Zogopoulos; Anne-Marie O'Shea; Aaron Pollett; Steven Gallinger
Journal:  Hum Genet       Date:  2008-09-02       Impact factor: 4.132

7.  Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.

Authors:  A Moran; C O'Hara; S Khan; L Shack; E Woodward; E R Maher; F Lalloo; D G R Evans
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

Review 8.  Cancer risks among BRCA1 and BRCA2 mutation carriers.

Authors:  E Levy-Lahad; E Friedman
Journal:  Br J Cancer       Date:  2007-01-15       Impact factor: 7.640

Review 9.  Overview of the genetic basis toward early detection of breast cancer.

Authors:  Sumadee De Silva; Kamani Hemamala Tennekoon; Eric Hamilton Karunanayake
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-01-21

Review 10.  Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

Authors:  Davide Angeli; Samanta Salvi; Gianluca Tedaldi
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.